Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03793894 · ClinicalTrials.gov registry record · NA
Inpatient Smokers and LDCT Screening Part 2
A NA study, sponsored by Boston University.
- Completed
- Registry status
- NA
- Development phase
- 21
- Enrollment target
NCT03793894 is a NA study that has completed, run by Boston University. The registered enrollment target is 21 participants.
The verdict
NCT03793894, a NA study, has completed, sponsored by Boston University.
- COMPLETED
- Registry status
- NA
- Development phase
- 21 participants
- Enrollment target
Study Summary
Lung cancer suffers from large racial and socioeconomic disparities. Yet those at the highest risk of lung cancer death - current smokers, blacks, and individuals with low socioeconomic status (SES) and negative social determinants of health (SDH) - are less likely to receive preventive health services, including the two most effective interventions to reduce lung cancer mortality: tobacco dependence treatment and lung cancer screening (LCS) with low-dose computed tomography (LDCT). At Boston Medical Center (BMC) these preventive services are grossly underutilized, in part due to barriers our patients face in accessing these outpatient programs. Innovative approaches are needed to guide high-risk smokers to post-discharge early lung cancer detection services. The overarching goal of this study is to reduce disparities in lung cancer morbidity and mortality by using hospitalization at an urban safety net hospital as an opportunity to connect high-risk smokers to both LDCT lung cancer screening and tobacco dependence treatment. In addition to inpatient shared decision making \[SDM\] by an NP using a decision aid, screen-eligible smokers will also be connected with a community health worker (CHW) to facilitate access to outpatient smoking cessation counseling and LCS (CHW navigation).
Interventions
- BEHAVIORAL Decision Aid
- BEHAVIORAL Smoking Cessation Counseling
- BEHAVIORAL Shared decision making (SDM)
- BEHAVIORAL CHW Navigation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2019-02-12 |
| Est. Completion | 2020-06-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03793894
The ClinicalTrials.gov registry entry for NCT03793894 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston University, which has 185 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Decision Aid is the first listed.
NCT03793894 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03793894 about?
NCT03793894 is a clinical study titled "Inpatient Smokers and LDCT Screening Part 2". Lung cancer suffers from large racial and socioeconomic disparities. Yet those at the highest risk of lung cancer death - current smokers, blacks, and individuals with low socioeconomic status (SES) and negative social determinants of health (SDH) - are less likely to receive preventive health servi...
What is the current status of trial NCT03793894?
This trial is currently completed. It is a NA study. The enrollment target is 21 participants. The study started on 2019-02-12. Estimated completion is 2020-06-04.
What interventions are being tested in trial NCT03793894?
The interventions under investigation include: Decision Aid (BEHAVIORAL), Smoking Cessation Counseling (BEHAVIORAL), Shared decision making (SDM) (BEHAVIORAL), CHW Navigation (BEHAVIORAL).
Who is sponsoring clinical trial NCT03793894?
This trial is sponsored by Boston University, which has 185 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.